Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.

Melkamu T, Zhang X, Tan J, Zeng Y, Kassie F.

Carcinogenesis. 2010 Feb;31(2):252-8. doi: 10.1093/carcin/bgp208. Epub 2009 Sep 11.

PMID:
19748927
2.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

PMID:
20363096
3.

Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice.

Gunning WT, Kramer PM, Lubet RA, Steele VE, Pereira MA.

Exp Lung Res. 2000 Dec;26(8):757-72.

PMID:
11195469
4.

Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.

Pereira MA, Li Y, Gunning WT, Kramer PM, Al-Yaqoub F, Lubet RA, Steele VE, Szabo E, Tao L.

Carcinogenesis. 2002 Jul;23(7):1185-92.

PMID:
12117777
5.

The role of microRNA in human lung squamous cell carcinoma.

Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, Ma Q, Wang YJ.

Cancer Genet Cytogenet. 2010 Jul 15;200(2):127-33. doi: 10.1016/j.cancergencyto.2010.03.014.

PMID:
20620595
6.

Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.

Kassie F, Kalscheuer S, Matise I, Ma L, Melkamu T, Upadhyaya P, Hecht SS.

Carcinogenesis. 2010 Feb;31(2):239-45. doi: 10.1093/carcin/bgp174. Epub 2009 Jul 22.

7.

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A.

J Pathol. 2009 Oct;219(2):214-21. doi: 10.1002/path.2586.

PMID:
19593777
8.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, FoĆ  R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
9.

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.

Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y.

Eur J Cancer. 2010 Jun;46(9):1692-702. doi: 10.1016/j.ejca.2010.02.043. Epub 2010 Apr 3.

PMID:
20371173
10.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

11.

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW.

Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26.

12.

Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.

Kang Y, Ozbun LL, Angdisen J, Moody TW, Prentice M, Diwan BA, Jakowlew SB.

Carcinogenesis. 2002 Jul;23(7):1217-27.

PMID:
12117781
13.

Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.

Tao L, Li Y, Wang W, Kramer PM, Gunning WT, Lubet RA, Steele VE, Pereira MA.

Mol Carcinog. 2002 Oct;35(2):93-102.

PMID:
12325039
14.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.

Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.

15.

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J.

PLoS One. 2009 Aug 18;4(8):e6677. doi: 10.1371/journal.pone.0006677.

16.

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.

Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.

PMID:
19475450
17.

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M.

Int J Oncol. 2009 Apr;34(4):1069-75.

PMID:
19287964
18.

Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors.

Mitsumori K, Wakana S, Yamamoto S, Kodama Y, Yasuhara K, Nomura T, Hayashi Y, Maronpot RR.

Mol Carcinog. 1997 Nov;20(3):298-307.

PMID:
9397190
19.

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.

Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.

20.

Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.

Kang Y, Mariano JM, Angdisen J, Moody TW, Diwan BA, Wakefield LM, Jakowlew SB.

Mol Carcinog. 2000 Oct;29(2):112-26.

PMID:
11074608

Supplemental Content

Support Center